- Home
- CTLP vs KALV Comparison
CTLP vs KALV Comparison
Compare CTLP & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTLP
- KALV
- Stock Information
- Founded
- CTLP 1992
- KALV N/A
- Country
- CTLP United States
- KALV United States
- Employees
- CTLP N/A
- KALV N/A
- Industry
- CTLP EDP Services
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- CTLP Technology
- KALV Health Care
- Exchange
- CTLP Nasdaq
- KALV Nasdaq
- Market Cap
- CTLP 623.0M
- KALV 563.1M
- IPO Year
- CTLP N/A
- KALV N/A
- Fundamental
- Price
- CTLP $7.57
- KALV $11.93
- Analyst Decision
- CTLP Strong Buy
- KALV Strong Buy
- Analyst Count
- CTLP 4
- KALV 8
- Target Price
- CTLP $12.50
- KALV $24.83
- AVG Volume (30 Days)
- CTLP 441.3K
- KALV 619.3K
- Earning Date
- CTLP 05-08-2025
- KALV 03-12-2025
- Dividend Yield
- CTLP N/A
- KALV N/A
- EPS Growth
- CTLP N/A
- KALV N/A
- EPS
- CTLP 0.19
- KALV N/A
- Revenue
- CTLP $285,112,000.00
- KALV N/A
- Revenue This Year
- CTLP $18.00
- KALV N/A
- Revenue Next Year
- CTLP $15.55
- KALV N/A
- P/E Ratio
- CTLP $39.85
- KALV N/A
- Revenue Growth
- CTLP 12.88
- KALV N/A
- 52 Week Low
- CTLP $5.75
- KALV $7.30
- 52 Week High
- CTLP $11.36
- KALV $15.50
- Technical
- Relative Strength Index (RSI)
- CTLP 33.03
- KALV 54.49
- Support Level
- CTLP $7.69
- KALV $11.83
- Resistance Level
- CTLP $8.08
- KALV $12.58
- Average True Range (ATR)
- CTLP 0.35
- KALV 0.59
- MACD
- CTLP -0.00
- KALV -0.12
- Stochastic Oscillator
- CTLP 8.55
- KALV 22.40
About CTLP Cantaloupe Inc.
Cantaloupe Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Cashless devices, eSuds, EnergyMisers, and Value-added services which include Loyalty and Prepaid, Intelligent Vending, and others. The company offers services to different industries covering car wash, taxi and transportation, laundry, vending, kiosk, amusement, and arcade. The company derives revenue from the sale or lease of equipment and services to the small ticket, unattended POS market, and the majority of its revenue is derived from subscription and transaction fees.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.